Stay up to date with notifications from The Independent

Notifications can be managed in browser preferences.

Martha Stewart may face jail over shares sale

David Usborne
Wednesday 04 June 2003 00:00 BST
0Comments

Your support helps us to tell the story

From reproductive rights to climate change to Big Tech, The Independent is on the ground when the story is developing. Whether it's investigating the financials of Elon Musk's pro-Trump PAC or producing our latest documentary, 'The A Word', which shines a light on the American women fighting for reproductive rights, we know how important it is to parse out the facts from the messaging.

At such a critical moment in US history, we need reporters on the ground. Your donation allows us to keep sending journalists to speak to both sides of the story.

The Independent is trusted by Americans across the entire political spectrum. And unlike many other quality news outlets, we choose not to lock Americans out of our reporting and analysis with paywalls. We believe quality journalism should be available to everyone, paid for by those who can afford it.

Your support makes all the difference.

Martha Stewart, whose name is synonymous in America with home design and affordable gracious living, may soon be trading her salad servers for handcuffs after an admission from her company yesterday that she is facing criminal charges in a long- running insider trading case.

The style maven, who rose to fame and fortune with books, magazines and syndicated television shows, could be charged today. Her lawyers indicated she would plead innocence.

Ms Stewart's holding company, Martha Stewart Omnimedia, released the news before the start of an annual general meeting of shareholders in Manhattan. Ms Stewart, 61, its chief executive officer and chairwoman, did not attend.

The case centres on Ms Stewart's friendship with Sam Waksal, the disgraced former head of a biotech company named ImClone. Mr Waksal pleaded guilty last year to selling shares in ImClone in December 2001, one day before federal regulators refused a licence for a cancer drug it was developing.

Investigators have been trying to establish whether Mr Waksal, who will be sentenced next week, also tipped off some of his friends about the impending setback, Ms Stewart among them.

The same day, she sold 4,000 shares in the company worth $225,000 (£138,000). She claimed she had arranged with her broker to offload the ImClone shares if their price fell below a certain level.

Her lawyers made a last effort to forestall charges by trying to recruit help from senior Department of Justice officials in Washington last week. But attempts to secure meetings with them were refused.

There was no word from prosecutors in Manhattan about likely charges, but they may concern only obstruction of justice rather than more serious insider trading. But she could still face prison.

Join our commenting forum

Join thought-provoking conversations, follow other Independent readers and see their replies

0Comments

Thank you for registering

Please refresh the page or navigate to another page on the site to be automatically logged inPlease refresh your browser to be logged in